153 related articles for article (PubMed ID: 14678029)
1. New B7 family members with positive and negative costimulatory function.
Rietz C; Chen L
Am J Transplant; 2004 Jan; 4(1):8-14. PubMed ID: 14678029
[TBL] [Abstract][Full Text] [Related]
2. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
Khoury SJ; Sayegh MH
Immunity; 2004 May; 20(5):529-38. PubMed ID: 15142522
[TBL] [Abstract][Full Text] [Related]
3. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
[TBL] [Abstract][Full Text] [Related]
4. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
Tseng SY; Otsuji M; Gorski K; Huang X; Slansky JE; Pai SI; Shalabi A; Shin T; Pardoll DM; Tsuchiya H
J Exp Med; 2001 Apr; 193(7):839-46. PubMed ID: 11283156
[TBL] [Abstract][Full Text] [Related]
5. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
6. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
Blank C; Gajewski TF; Mackensen A
Cancer Immunol Immunother; 2005 Apr; 54(4):307-14. PubMed ID: 15599732
[TBL] [Abstract][Full Text] [Related]
7. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH
J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455
[TBL] [Abstract][Full Text] [Related]
8. T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity.
Foell J; Hewes B; Mittler RS
Curr Cancer Drug Targets; 2007 Feb; 7(1):55-70. PubMed ID: 17305478
[TBL] [Abstract][Full Text] [Related]
9. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
Carreno BM; Collins M
Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of T-cell function by PD-1.
Zha Yy; Blank C; Gajewski TF
Crit Rev Immunol; 2004; 24(4):229-37. PubMed ID: 15588223
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
12. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Hathcock KS; Laszlo G; Pucillo C; Linsley P; Hodes RJ
J Exp Med; 1994 Aug; 180(2):631-40. PubMed ID: 7519245
[TBL] [Abstract][Full Text] [Related]
14. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
15. The right place at the right time: novel B7 family members regulate effector T cell responses.
Liang L; Sha WC
Curr Opin Immunol; 2002 Jun; 14(3):384-90. PubMed ID: 11973139
[TBL] [Abstract][Full Text] [Related]
16. Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
Truong W; Hancock WW; Anderson CC; Merani S; Shapiro AM
Cell Transplant; 2006; 15(2):105-19. PubMed ID: 16719045
[TBL] [Abstract][Full Text] [Related]
17. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.
Selenko-Gebauer N; Majdic O; Szekeres A; Höfler G; Guthann E; Korthäuer U; Zlabinger G; Steinberger P; Pickl WF; Stockinger H; Knapp W; Stöckl J
J Immunol; 2003 Apr; 170(7):3637-44. PubMed ID: 12646628
[TBL] [Abstract][Full Text] [Related]
18. Programmed death-1 targeting can promote allograft survival.
Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
[TBL] [Abstract][Full Text] [Related]
19. The expanding world of co-stimulation: the two-signal model revisited.
Chambers CA
Trends Immunol; 2001 Apr; 22(4):217-23. PubMed ID: 11274928
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
